Namodenoson Not Yet Recruiting Phase 2 Trials for Pancreatic Cancer / Pancreatic Adenocarcinoma Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT06387342Namodenoson Treatment of Advanced Pancreatic Cancer